You Are Here: Home > About Arthritis > Arthritis in the News > Arthritis Society joins Genome Canada to invest in research to Stop Childhood Arthritis

Arthritis Society joins Genome Canada to invest in research to Stop Childhood Arthritis

The Arthritis Society is very proud to be joining Genome Canada’s announcement today of $10 million in new funding to accelerate research into personalized medicine for childhood arthritis.

As the only charity contributing to this initiative, the Arthritis Society will invest $1 million, while the remainder will come from Genome Canada, Ontario Genomics, Genome Alberta, SickKids and Alberta Children’s Hospital. The funding is part of a blockbuster $255 million commitment announced by the federal government to support genomic research.

This is the next important phase of Stop Childhood Arthritis, the five-year commitment we announced last year that is funding research aimed at stopping childhood arthritis in its tracks.

This is an investment in children, and in discovery. The future of arthritis care is going to be driven by a focus on innovation. This initiative is a game-changer with potential implications for arthritis care that extend far beyond children.

The Arthritis Society is excited to be helping lead the way with the generous support of our donors, who can help support this initiative by visiting stopchildhoodarthritis.ca.

Back to News